ABBV vs. AMGN: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ABBV and AMGN, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
ABBV dominates in value with a market cap of 321.13 billion USD, eclipsing AMGN’s 145.90 billion USD by roughly 2.20×.
With betas of 0.55 for ABBV and 0.50 for AMGN, both show similar volatility profiles relative to the overall market.
| Symbol | ABBV | AMGN |
|---|---|---|
| Company Name | AbbVie Inc. | Amgen Inc. |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| CEO | Mr. Robert A. Michael CPA | Mr. Robert A. Bradway |
| Price | 181.8 USD | 271.34 USD |
| Market Cap | 321.13 billion USD | 145.90 billion USD |
| Beta | 0.55 | 0.50 |
| Exchange | NYSE | NASDAQ |
| IPO Date | January 2, 2013 | June 17, 1983 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ABBV and AMGN over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between ABBV and AMGN, please refer to the table below.
| Symbol | ABBV | AMGN |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 76.62 | 24.60 |
| Forward PEG Ratio (TTM) | 7.16 | 7.08 |
| Price-to-Sales Ratio (P/S, TTM) | 5.60 | 4.28 |
| Price-to-Book Ratio (P/B, TTM) | 226.35 | 23.52 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 20.87 | 13.37 |
| EV-to-EBITDA (TTM) | 23.58 | 15.71 |
| EV-to-Sales (TTM) | 6.73 | 5.70 |
| EV-to-Free Cash Flow (TTM) | 25.08 | 17.82 |
Dividend Comparison
Both ABBV and AMGN offer similar dividend yields (3.51% vs. 3.41%), indicating comparable approaches to balancing income and growth.
| Symbol | ABBV | AMGN |
|---|---|---|
| Dividend Yield (TTM) | 3.51% | 3.41% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ABBV and AMGN, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- ABBV’s current ratio of 0.76 signals a possible liquidity squeeze, while AMGN at 1.17 comfortably covers its short-term obligations.
- ABBV’s quick ratio of 0.64 suggests it may struggle to cover immediate liabilities without selling inventory or raising cash, whereas AMGN at 0.88 maintains a comfortable buffer of liquid assets.
- ABBV and AMGN both have debt-to-equity ratios above 3 (49.22 and 9.24), reflecting aggressive use of debt that can amplify gains but also increase vulnerability to rising rates.
| Symbol | ABBV | AMGN |
|---|---|---|
| Current Ratio (TTM) | 0.76 | 1.17 |
| Quick Ratio (TTM) | 0.64 | 0.88 |
| Debt-to-Equity Ratio (TTM) | 49.22 | 9.24 |
| Debt-to-Assets Ratio (TTM) | 0.51 | 0.64 |
| Interest Coverage Ratio (TTM) | 6.14 | 3.19 |